Clinical Decision Support Tool for Heart Failure
Trial Summary
What is the purpose of this trial?
To work best, clinical decision support tools (CDS) must be timed to provide support when healthcare decisions are made, which includes virtual visits (phone or video). Unfortunately, most CDS tools are either missing from virtual visits or not designed for the unique context of virtual visits (e.g., availability of physical assessments and labs, different workflows), which could generate new inequities for patients more likely to use virtual visits. The objective of this study is to test the reach, feasibility and acceptability of a new CDS tool for heart failure with reduced ejection fraction (HFrEF) during virtual visits. This new CDS tool was developed through an iterative design process, and will be compared to an existing HFrEF CDS tool in a randomized pilot study at outpatient cardiology clinics throughout the UCHealth system.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What data supports the effectiveness of the treatment Iteratively designed (new) clinical decision support tool for virtual visits for heart failure?
Research on similar tools, like a web-based symptom monitoring tool for heart failure, shows that patients and clinicians found it helpful for tracking symptoms and communicating with doctors. Additionally, telemedicine support has been shown to potentially improve patient outcomes in heart failure management.12345
How is the new clinical decision support tool for heart failure different from other treatments?
Research Team
Katy Trinkley, PharmD, PhD
Principal Investigator
University of Colorado, Denver
Eligibility Criteria
This trial is for clinicians with prescribing privileges at UCHealth's outpatient cardiology clinics. It observes their use of clinical decision support tools during virtual visits for heart failure patients, and also considers patient characteristics that might influence prescriptions.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are exposed to either the new or traditional CDS tool during virtual visits to evaluate reach, feasibility, and acceptability
Follow-up
Participants are monitored for the number of patients uploading vitals and other secondary outcomes
Treatment Details
Interventions
- Iteratively designed (new) clinical decision support tool for virtual visits
Find a Clinic Near You
Who Is Running the Clinical Trial?
Katy E Trinkley
Lead Sponsor
University of Colorado, Denver
Lead Sponsor
American Heart Association (AHA)
Collaborator